Gsk (GLAXF) Change in Cash (2009 - 2026)

Gsk's Change in Cash history runs 18 years deep, the most recent figure standing at -$71.5 million for Q1 2026.

• In Q1 2026, Change in Cash fell 106.6% year-over-year to -$71.5 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 34.65% YoY), while the FY2025 annual figure was -$233.4 million, down 130.48% from the prior year.
• Change in Cash was -$71.5 million for Q1 2026 at Gsk, down from $1.1 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $9.3 billion in Q1 2022 to a low of -$818.0 million in Q1 2023.
• Historically, Change in Cash has averaged $1.7 billion across 5 years, with a median of $200.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Cash jumped 716.27% in 2022, then sank 108.97% in 2023.
• A 5-year view of Change in Cash shows it stood at $4.1 billion in 2022, then tumbled by 108.97% to -$371.1 million in 2023, then surged by 227.28% to $472.3 million in 2024, then jumped by 129.06% to $1.1 billion in 2025, then slumped by 106.6% to -$71.5 million in 2026.
• The last three Change in Cash figures came in at -$71.5 million (Q1 2026), $1.1 billion (Q1 2025), and $472.3 million (Q4 2024), per Business Quant data.